Literature DB >> 30218134

[Present hormonal birth control and the risk of breast cancer].

Georg Sauer1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30218134     DOI： 10.1007/s00066-018-1372-5

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

1.  Menopause Management--Getting Clinical Care Back on Track.

Authors:  JoAnn E Manson; Andrew M Kaunitz
Journal:  N Engl J Med       Date:  2016-03-03       Impact factor: 91.245

2.  The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.

Authors:  G A Colditz; S E Hankinson; D J Hunter; W C Willett; J E Manson; M J Stampfer; C Hennekens; B Rosner; F E Speizer
Journal:  N Engl J Med       Date:  1995-06-15       Impact factor: 91.245

3.  Mortality among contraceptive pill users: cohort evidence from Royal College of General Practitioners' Oral Contraception Study.

Authors:  Philip C Hannaford; Lisa Iversen; Tatiana V Macfarlane; Alison M Elliott; Valerie Angus; Amanda J Lee
Journal:  BMJ       Date:  2010-03-11

4.  Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland.

Authors:  Tuuli Soini; Ritva Hurskainen; Seija Grénman; Johanna Mäenpää; Jorma Paavonen; Eero Pukkala
Journal:  Obstet Gynecol       Date:  2014-08       Impact factor: 7.661

5.  Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

Authors:  Rowan T Chlebowski; Susan L Hendrix; Robert D Langer; Marcia L Stefanick; Margery Gass; Dorothy Lane; Rebecca J Rodabough; Mary Ann Gilligan; Michele G Cyr; Cynthia A Thomson; Janardan Khandekar; Helen Petrovitch; Anne McTiernan
Journal:  JAMA       Date:  2003-06-25       Impact factor: 56.272

6.  Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials.

Authors:  JoAnn E Manson; Rowan T Chlebowski; Marcia L Stefanick; Aaron K Aragaki; Jacques E Rossouw; Ross L Prentice; Garnet Anderson; Barbara V Howard; Cynthia A Thomson; Andrea Z LaCroix; Jean Wactawski-Wende; Rebecca D Jackson; Marian Limacher; Karen L Margolis; Sylvia Wassertheil-Smoller; Shirley A Beresford; Jane A Cauley; Charles B Eaton; Margery Gass; Judith Hsia; Karen C Johnson; Charles Kooperberg; Lewis H Kuller; Cora E Lewis; Simin Liu; Lisa W Martin; Judith K Ockene; Mary Jo O'Sullivan; Lynda H Powell; Michael S Simon; Linda Van Horn; Mara Z Vitolins; Robert B Wallace
Journal:  JAMA       Date:  2013-10-02       Impact factor: 56.272

7.  Oral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort study.

Authors:  Brittany M Charlton; Janet W Rich-Edwards; Graham A Colditz; Stacey A Missmer; Bernard A Rosner; Susan E Hankinson; Frank E Speizer; Karin B Michels
Journal:  BMJ       Date:  2014-10-31

8.  Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.

Authors:  Lisa Iversen; Selvaraj Sivasubramaniam; Amanda J Lee; Shona Fielding; Philip C Hannaford
Journal:  Am J Obstet Gynecol       Date:  2017-02-08       Impact factor: 8.661
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.